VDGH Managing Director Dr. Martin Walger emphasizes: "The digital revolution in healthcare offers enormous opportunities to improve the treatment of diabetes patients. However, the current legal regulations are an obstacle that limits the full potential of these technologies."
Digital health applications (DiGA) and in vitro diagnostics (IVD) could play a crucial role in improving care for diabetes patients who self-monitor their glucose levels. These patients could benefit from DiGAs that are able to directly integrate and analyze the measurement data from the device. This integration would improve the quality of life of diabetic patients by enabling more accurate monitoring and individually tailored treatment approaches. In addition, the more precise monitoring of health status would be a significant advance over the error-prone manual input of values.
The VDGH therefore sees an urgent need for change, particularly in the definition of digital health applications, in order to exploit the full potential of digitalization for diabetes care. The association calls on the legislator to reconsider and adapt the existing restrictions in the DigiG. This would not only improve patient care, but would also further drive digital innovation in the healthcare sector.
